Skip to main content

Advertisement

SpringerLink
Log in

Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Biomedical approaches to HIV prevention (eg, microbicides, antiretroviral preexposure prophylaxis) are undergoing clinical trials to test their efficacy. One key consideration emerging from completed trials is the critical role of adherence to the investigational product. Suboptimal product adherence may compromise clinical trial results and ultimately undermine the effectiveness of biomedical prevention methods in any future real-world use. Efforts to strengthen biomedical HIV prevention product adherence can benefit from existing research methodologies, findings, and interventions developed for adherence to HIV treatment. Research on treatment adherence is most relevant to medication-based biomedical prevention strategies, such as antiretroviral preexposure prophylaxis and acyclovir for herpes simplex virus-2. Three areas where HIV treatment adherence literature can inform research on such biomedical prevention strategies are 1) specialized methods for assessing medication adherence, 2) research findings emphasizing social context as an adherence determinant, and 3) promising behavioral interventions to improve adherence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Holtgrave D: Evidence-based efforts to prevent HIV infection: an overview of current status and future challenges. Clin Infect Dis 2007, 45(Suppl 4):S293–S299.

    Article  PubMed  Google Scholar 

  2. Green EC, Halperin DT, Natulya V, Hogle JA: Uganda’s HIV prevention success: the role of sexual behavior change and the national response. AIDS Behav 2006, 10:335–346.

    Article  PubMed  Google Scholar 

  3. Gray RH, Kigozi G, Serwadda D, et al.: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007, 369:657–666.

    Article  PubMed  Google Scholar 

  4. Padian NS, van der Straten A, Ramjee G, et al.: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007, 370:251–261.

    Article  PubMed  Google Scholar 

  5. Watson-Jones D, Weiss HA, Rusizoka M, et al.: Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008, 358:1560–1571.

    Article  PubMed  CAS  Google Scholar 

  6. Cohen J: Microbicide fails to protect against HIV. Science 2008, 319:1026–1027.

    Article  PubMed  CAS  Google Scholar 

  7. Peterson L, Taylor D, Roddy R, et al.: Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007, 2:e27.

    Article  PubMed  CAS  Google Scholar 

  8. Lagakos SW, Gable AR, eds: Methodological Challenges in Biomedical HIV Prevention Trials. Washington DC: National Academies Press; 2008.

    Google Scholar 

  9. Giordano TP, Gifford AL, White AC, et al.: Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 2007, 44:1493–1499.

    Article  PubMed  Google Scholar 

  10. Stirratt MJ, Gordon CM: HIV treatment adherence research and intervention: current advances and future challenges. J HIV/AIDS Soc Serv 2007, 6:9–22.

    Article  Google Scholar 

  11. Bradford JB: The promise of outreach for engaging and retaining out-of-care persons in HIV medical care. AIDS Patient Care STDS 2007, 21(Suppl 1):S85–S91.

    PubMed  Google Scholar 

  12. Fisher M: Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis 2008, 21:1–3.

    PubMed  Google Scholar 

  13. Branson BJ: Current HIV epidemiology and revised recommendations for HIV testing in health-care settings. Med Virol 2007, 79(Suppl 1):S6–S10.

    Article  Google Scholar 

  14. Gao X, Nau DP, Rosenbluth SA, et al.: The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000, 12:387–398.

    Article  PubMed  CAS  Google Scholar 

  15. Arnsten JH, Demas PA, Farzadegan H, et al.: Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 2001, 33:1417–1423.

    Article  PubMed  CAS  Google Scholar 

  16. Miller LG, Hays RD: Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials 2000, 1:36–46.

    Article  PubMed  CAS  Google Scholar 

  17. Bell DJ, Kapitao Y, Sikwese R, et al.: Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr 2007, 45:560–563.

    Article  PubMed  Google Scholar 

  18. Chesney MA: The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 2006, 43(Suppl 1):S149–S155.

    PubMed  Google Scholar 

  19. Simoni JM, Kurth AE, Pearson, CR, et al.: Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav 2006, 10:227–245.

    Article  PubMed  Google Scholar 

  20. Bangsberg DR, Bronstone A, Chesney MA, Hecht FM: Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. J Acquir Immune Defic Syndr 2002, 31(Suppl 3):S107–S111.

    PubMed  Google Scholar 

  21. Chesney MA, Ickovics JR, Chambers DB, et al.: Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2000, 12:255–266.

    Article  PubMed  CAS  Google Scholar 

  22. Lu M, Safren SA, Skolnik PR, et al.: Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 2008, 12:86–94.

    Article  PubMed  Google Scholar 

  23. Kalichman SC, Cain D, Fuhrel A, et al.: Assessing medication adherence self-efficacy among low-literacy patients: development of a pictographic visual analogue scale. Health Educ Res 2004, 20:24–35.

    Article  PubMed  Google Scholar 

  24. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al.: Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004, 36:1100–1102.

    Article  PubMed  CAS  Google Scholar 

  25. Hogarty K, Kasowitz A, Herold BC, Keller MJ: Assessment of adherence to product dosing in a pilot microbicide study. Sex Transm Dis 2007, 34:1000–1003.

    PubMed  Google Scholar 

  26. Bangsberg DR, Hecht FM, Charlebois ED, et al.: Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav 2001, 5:275–281.

    Article  Google Scholar 

  27. Kalichman SC, Amarai CM, Stearns H, et al.: Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Int Med 2007, 22:1003–1006.

    Article  Google Scholar 

  28. Liu H, Golin CE, Miller LG, et al.: A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001, 134:968–977.

    PubMed  CAS  Google Scholar 

  29. Mills EJ, Nachega JB, Buchan I, et al.: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006, 296:679–690.

    Article  PubMed  CAS  Google Scholar 

  30. Bangsberg DR, Ware N, Simoni J: Adherence without access to antiretroviral therapy in sub-Saharan Africa? AIDS 2006, 20:140–141.

    Article  PubMed  Google Scholar 

  31. Johnson KE, Quinn TC: Update on male circumcision: prevention success and challenges ahead. Curr Infect Dis Rep 2008, 10:243–251.

    Article  PubMed  Google Scholar 

  32. Oyugi JH, Byakika-Tusiime J, Ragland K, et al.: Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007, 21:965–971.

    Article  PubMed  CAS  Google Scholar 

  33. Ware NC, Wyatt MA, Tugenberg T: Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care 2006, 18:904–910.

    Article  PubMed  CAS  Google Scholar 

  34. Ramadhani HO, Thielman NM, Landman KZ, et al.: Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 2007, 45:1492–1498.

    Article  PubMed  Google Scholar 

  35. Behforouz HL, Farmer PE, Mukherjee JS: From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis 2004, 38(Suppl 5):S429–S436.

    Article  PubMed  Google Scholar 

  36. Simoni JM, Pearson CR, Pantalone DW, et al.: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. J Acquir Immune Defic Synd 2006, 43(Suppl 1):S23–S35.

    Article  Google Scholar 

  37. Pradier C, Bentz L, Spire B, et al.: Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials 2003, 4:121–131.

    Article  PubMed  Google Scholar 

  38. Reynolds NR, Testa MA, Su M, et al.: Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Synd 2008, 47:62–68.

    Google Scholar 

  39. Petersen ML, Wang Y, van der Laan MJ, et al.: Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis 2007, 45:908–915.

    Article  PubMed  CAS  Google Scholar 

  40. Celum C, Wald A, Hughes J, et al.: Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371:2109–2119.

    Article  PubMed  CAS  Google Scholar 

  41. Remien RH, Stirratt MJ, Dolezal C, et al.: Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS 2005, 19:807–814.

    Article  PubMed  Google Scholar 

  42. Rosen MI, Dieckhaus K, McMahon TJ, et al.: Improved adherence with contingency management. AIDS Patient Care STDS 2007, 21:30–40.

    Article  PubMed  Google Scholar 

  43. Williams AB, Fennie KP, Bova CA, et al.: Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial. J Acquir Immune Defic Syndr 2007, 42:314–321.

    Google Scholar 

  44. Pearson CR, Micek MA, Simoni JM, et al.: Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr 2007, 46:238–244.

    Article  PubMed  CAS  Google Scholar 

  45. Goggin K, Liston RJ, Mitty JA: Modified directly observed therapy for antiretroviral therapy: a primer from the field. Public Health Rep 2007, 122:472–481.

    PubMed  Google Scholar 

  46. Gray RH, Wawer MJ: Randomised trials of HIV prevention. Lancet 2007, 370:200–201.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Mental Health Research on AIDS, National Institute of Mental Health, 6001 Executive Boulevard, Room 6199, Bethesda, MD, 20892, USA

    Michael J. Stirratt

Authors
  1. Michael J. Stirratt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher M. Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Stirratt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stirratt, M.J., Gordon, C.M. Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep 5, 186–192 (2008). https://doi.org/10.1007/s11904-008-0027-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-008-0027-z

Keywords

Search

Navigation